Skip to main content
NCBI home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1992 Feb;33(2):155–160. doi: 10.1111/j.1365-2125.1992.tb04018.x

The effect of saturation of ACE binding sites on the pharmacokinetics of enalaprilat in man.

J R Wade 1, P A Meredith 1, D M Hughes 1, H L Elliott 1
PMCID: PMC1381301  PMID: 1312853

Abstract

1. Eight healthy male volunteers received oral enalapril, 10 mg, in the presence and absence of pretreatment with captopril, 50 mg, twice daily for 5 days. 2. Enalaprilat pharmacokinetics were characterised after both doses of enalapril to investigate the effect of saturating ACE binding sites by pretreatment with captopril. 3. The pharmacokinetics of enalaprilat were best described by a one compartment model with zero order input incorporating saturable binding to plasma and tissue ACE. 4. Values of AUC (0.72 h) for enalaprilat were 419 +/- 97 and 450 +/- 87 ng ml-1 h in the presence and absence of captopril, respectively. The difference was not statistically significant nor were there any other differences in model parameters. 5. Induction of ACE by captopril resulting in an increase in the number of ACE binding sites, may have obscured any effect of captopril on the occupancy of ACE binding sites by enalapril.

Full text

PDF
155

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beneteau B., Baudin B., Morgant G., Giboudeau J., Baumann F. C. Automated kinetic assay of angiotensin-converting enzyme in serum. Clin Chem. 1986 May;32(5):884–886. [PubMed] [Google Scholar]
  2. Boomsma F., de Bruyn J. H., Derkx F. H., Schalekamp M. A. Opposite effects of captopril on angiotensin I-converting enzyme 'activity' and 'concentration'; relation between enzyme inhibition and long-term blood pressure response. Clin Sci (Lond) 1981 May;60(5):491–498. doi: 10.1042/cs0600491. [DOI] [PubMed] [Google Scholar]
  3. Chiknas S. G. A liquid chromatography-assisted assay for angiotensin-converting enzyme (peptidyl dipeptidase) in serum. Clin Chem. 1979 Jul;25(7):1259–1262. [PubMed] [Google Scholar]
  4. Duchin K. L., McKinstry D. N., Cohen A. I., Migdalof B. H. Pharmacokinetics of captopril in healthy subjects and in patients with cardiovascular diseases. Clin Pharmacokinet. 1988 Apr;14(4):241–259. doi: 10.2165/00003088-198814040-00002. [DOI] [PubMed] [Google Scholar]
  5. Duchin K. L., Singhvi S. M., Willard D. A., Migdalof B. H., McKinstry D. N. Captopril kinetics. Clin Pharmacol Ther. 1982 Apr;31(4):452–458. doi: 10.1038/clpt.1982.59. [DOI] [PubMed] [Google Scholar]
  6. Dzau V. J. Vascular angiotensin pathways: a new therapeutic target. J Cardiovasc Pharmacol. 1987;10 (Suppl 7):S9–16. [PubMed] [Google Scholar]
  7. Francis R. J., Brown A. N., Kler L., Fasanella d'Amore T., Nussberger J., Waeber B., Brunner H. R. Pharmacokinetics of the converting enzyme inhibitor cilazapril in normal volunteers and the relationship to enzyme inhibition: development of a mathematical model. J Cardiovasc Pharmacol. 1987 Jan;9(1):32–38. [PubMed] [Google Scholar]
  8. Fyhrquist F., Forslund T., Tikkanen I., Grönhagen-Riska C. Induction of angiotensin I-converting enzyme rat lung with Captopril (SQ 14225). Eur J Pharmacol. 1980 Oct 31;67(4):473–475. doi: 10.1016/0014-2999(80)90189-2. [DOI] [PubMed] [Google Scholar]
  9. Hayashi K., Miyamoto M., Sekine Y. Determination of captopril and its mixed disulphides in plasma and urine by high-performance liquid chromatography. J Chromatogr. 1985 Feb 27;338(1):161–169. doi: 10.1016/0378-4347(85)80080-3. [DOI] [PubMed] [Google Scholar]
  10. Jackson B., Cubela R. B., Johnston C. I. Effects of perindopril on angiotensin converting enzyme in tissues of the rat. J Hypertens Suppl. 1988 Dec;6(3):S51–S54. [PubMed] [Google Scholar]
  11. Jarrott B., Anderson A., Hooper R., Louis W. J. High-performance liquid chromatographic analysis of captopril in plasma. J Pharm Sci. 1981 Jun;70(6):665–667. doi: 10.1002/jps.2600700622. [DOI] [PubMed] [Google Scholar]
  12. Johnston C. I., Mendelsohn F. A., Cubela R. B., Jackson B., Kohzuki M., Fabris B. Inhibition of angiotensin converting enzyme (ACE) in plasma and tissues: studies ex vivo after administration of ACE inhibitors. J Hypertens Suppl. 1988 Dec;6(3):S17–S22. [PubMed] [Google Scholar]
  13. Kripalani K. J., McKinstry D. N., Singhvi S. M., Willard D. A., Vukovich R. A., Migdalof B. H. Disposition of captopril in normal subjects. Clin Pharmacol Ther. 1980 May;27(5):636–641. doi: 10.1038/clpt.1980.90. [DOI] [PubMed] [Google Scholar]
  14. Lees K. R., Kelman A. W., Reid J. L., Whiting B. Pharmacokinetics of an ACE inhibitor, S-9780, in man: evidence of tissue binding. J Pharmacokinet Biopharm. 1989 Oct;17(5):529–550. doi: 10.1007/BF01071348. [DOI] [PubMed] [Google Scholar]
  15. Meredith P. A., Elliott H. L., Reid J. L., Francis R. J. The pharmacokinetics and angiotensin converting enzyme inhibition dynamics of cilazapril in essential hypertension. Br J Clin Pharmacol. 1989;27 (Suppl 2):263S–266S. doi: 10.1111/j.1365-2125.1989.tb03490.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Nussberger J., Brunner D. B., Waeber B., Biollaz J., Brunner H. R. Lack of angiotensin I accumulation after converting enzyme blockade by enalapril or lisinopril in man. Clin Sci (Lond) 1987 Mar;72(3):387–389. doi: 10.1042/cs0720387. [DOI] [PubMed] [Google Scholar]
  17. Rohrbach M. S. [Glycine-1-14C]hippuryl-L-histidyl-L-leucine: a substrate for the radiochemical assay of angiotensin converting enzyme. Anal Biochem. 1978 Jan;84(1):272–276. doi: 10.1016/0003-2697(78)90510-9. [DOI] [PubMed] [Google Scholar]
  18. Schalekamp M. A., Admiraal P. J., Derkx F. H. Estimation of regional metabolism and production of angiotensins in hypertensive subjects. Br J Clin Pharmacol. 1989;28 (Suppl 2):105S–113S. doi: 10.1111/j.1365-2125.1989.tb03586.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Schoenberger J. A., Wilson D. J. Once-daily treatment of essential hypertension with captopril. J Clin Hypertens. 1986 Dec;2(4):379–387. [PubMed] [Google Scholar]
  20. Swales J. D., Samani N. J. Localisation and physiological effects of tissue renin-angiotensin systems. J Hum Hypertens. 1989 Jun;3 (Suppl 1):71–77. [PubMed] [Google Scholar]
  21. Waldmeier F., Kaiser G., Ackermann R., Faigle J. W., Wagner J., Barner A., Lasseter K. C. The disposition of [14C]-labelled benazepril HCl in normal adult volunteers after single and repeated oral dose. Xenobiotica. 1991 Feb;21(2):251–261. doi: 10.3109/00498259109039467. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES